Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Rasoul Abdollah Zadeh, Nazanin Jalilian, Mohammad Ali Sahraian, Zeinab Kasraian & Mohammad Reza Noori-Daloii. (2017) Polymorphisms of RPS6KB1 and CD86 associates with susceptibility to multiple sclerosis in Iranian population. Neurological Research 39:3, pages 217-222.
Read now
Read now
Edward Keystone, Abdulaziz Alkhalaf & Mosaab Makkawy. (2015) Subcutaneous abatacept in rheumatoid arthritis: current update. Expert Opinion on Biological Therapy 15:8, pages 1221-1230.
Read now
Read now
Van Phi Luu, Monica I. Vazquez & Albert Zlotnik. (2014) B cells participate in tolerance and autoimmunity through cytokine production. Autoimmunity 47:1, pages 1-12.
Read now
Read now
Sarang Chitale & Robert Moots. (2008) Abatacept: the first T lymphocyte co-stimulation modulator, for the treatment of rheumatoid arthritis. Expert Opinion on Biological Therapy 8:1, pages 115-122.
Read now
Read now
Adriana H Tremoulet & Salvatore Albani. (2006) Novel therapies for rheumatoid arthritis. Expert Opinion on Investigational Drugs 15:11, pages 1427-1441.
Read now
Read now
. (2005) Isoforms of human B7-H3 co-signalling molecule for T cell activation as potential immunoregulatory agents. Expert Opinion on Therapeutic Patents 15:6, pages 745-749.
Read now
Read now
Heinz Wiendl & Bernd C Kieseier. (2003) Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies. Expert Opinion on Investigational Drugs 12:4, pages 689-712.
Read now
Read now
Articles from other publishers (34)
Jianshu Zhu, Jiawei Fan, Yuanliang Xia, Hengyi Wang, Yuehong Li, Zijia Feng & Changfeng Fu. (2023) Potential therapeutic targets of macrophages in inhibiting immune damage and fibrotic processes in musculoskeletal diseases. Frontiers in Immunology 14.
Crossref
Crossref
Stefan Busse, Franz von Hoff, Enrico Michler, Roland Hartig, Bernhard Bogerts & Mandy Busse. (2021) Altered expression of costimulatory molecules in dementias. European Archives of Psychiatry and Clinical Neuroscience 272:5, pages 807-815.
Crossref
Crossref
Mattia Bellan, Francesco Murano, Federico Ceruti, Cristina Piccinino, Stelvio Tonello, Rosalba Minisini, Ailia Giubertoni, Daniele Sola, Roberta Pedrazzoli, Veronica Maglione, Giulia Francesca Manfredi, Antonio Acquaviva, Roberto Piffero, Giuseppe Patti, Mario Pirisi & Pier Paolo Sainaghi. (2022) Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases. Diagnostics 12:3, pages 704.
Crossref
Crossref
Shaik SHAFIULLA & Suneela DHANESHWAR. (2022) Recent Advancements in Antipsoriatic Therapy: An Update. Fabad Journal of Pharmaceutical Sciences, pages 83-108.
Crossref
Crossref
Yu Fu, Leilei Wang, Wei Liu, Lan Yang, Lin Li, Luyao Wang, Xun Sun, Zhi-rong Zhang, Qing Lin & Ling Zhang. (2021) OX40L blockade cellular nanovesicles for autoimmune diseases therapy. Journal of Controlled Release 337, pages 557-570.
Crossref
Crossref
Liu Yang, Xinyan Han, Jinfeng Yuan, Faping Xing, Zhixing Hu, Fei Huang, Hui Wu, Hailian Shi, Ting Zhang & Xiaojun Wu. (2020) Early astragaloside IV administration attenuates experimental autoimmune encephalomyelitis in mice by suppressing the maturation and function of dendritic cells. Life Sciences 249, pages 117448.
Crossref
Crossref
Gonçalo Boleto, Yannick Allanore & Jérôme Avouac. (2018) Targeting Costimulatory Pathways in Systemic Sclerosis. Frontiers in Immunology 9.
Crossref
Crossref
David H. WagnerJr.Jr.. (2017) Overlooked Mechanisms in Type 1 Diabetes Etiology: How Unique Costimulatory Molecules Contribute to Diabetogenesis. Frontiers in Endocrinology 8.
Crossref
Crossref
Ameya S. Gokhale, Rushikesh Sable, Jason D. Walker, Leslie McLaughlin, Konstantin G. Kousoulas & Seetharama D. Jois. (2015) Inhibition of cell adhesion and immune responses in the mouse model of collagen-induced arthritis with a peptidomimetic that blocks CD2-CD58 interface interactions. Biopolymers 104:6, pages 733-742.
Crossref
Crossref
B L Levine. (2015) Performance-enhancing drugs: design and production of redirected chimeric antigen receptor (CAR) T cells. Cancer Gene Therapy 22:2, pages 79-84.
Crossref
Crossref
Xuebin Ji, Liping Zhang, Jun Peng & Ming Hou. (2014) T cell immune abnormalities in immune thrombocytopenia. Journal of Hematology & Oncology 7:1.
Crossref
Crossref
Mu Yang, Anthony Rainone, Xiang Qun Shi, Sylvie Fournier & Ji Zhang. (2014) A new animal model of spontaneous autoimmune peripheral polyneuropathy: implications for Guillain-Barré syndrome. Acta Neuropathologica Communications 2:1.
Crossref
Crossref
Ilse Van Brussel, Wai Ping Lee, Miche Rombouts, Amber H. Nuyts, Marthe Heylen, Benedicte Y. De Winter, Nathalie Cools & Dorien M. Schrijvers. (2014) Tolerogenic dendritic cell vaccines to treat autoimmune diseases: Can the unattainable dream turn into reality?. Autoimmunity Reviews 13:2, pages 138-150.
Crossref
Crossref
Chuda Chittasupho, Teruna J SiahaanCharlotte M Vines & Cory Berkland. (2011) Autoimmune therapies targeting costimulation and emerging trends in multivalent therapeutics. Therapeutic Delivery 2:7, pages 873-889.
Crossref
Crossref
Sara Ireland & Nancy Monson. (2011) Potential Impact of B Cells on T Cell Function in Multiple Sclerosis. Multiple Sclerosis International 2011, pages 1-9.
Crossref
Crossref
Petra Verdino, Deborah A. Witherden, M. Sharon Ferguson, Adam L. Corper, Andr? Schiefner, Wendy L. Havran & Ian A. Wilson. (2011) Molecular Insights into ?? T Cell Costimulation by an Anti-JAML Antibody. Structure 19:1, pages 80-89.
Crossref
Crossref
Roshan Dhawale & Larry W. Moreland. 2011. Rheumatology. Rheumatology
557
562
.
Heather MacLeod, Debra G. Goodwin, Christy Damphousse, Elisabeth Lonie, Xin Xu, Mary Collins & Cheryl L. Nickerson-Nutter. (2010) The DTH effector response and IL-2 are unaffected by cyclosporine A in autoimmune B6D2F1 mice. Cellular Immunology 266:1, pages 14-23.
Crossref
Crossref
Ping Zhang, Deming Sun, Yan Ke, Henry J. Kaplan & Hui Shao. (2007) The Net Effect of Costimulatory Blockers Is Dependent on the Subset and Activation Status of the Autoreactive T Cells. The Journal of Immunology 178:1, pages 474-479.
Crossref
Crossref
Heinz Wiendl & Reinhard Hohlfeld. 2007. Immune Regulation and Immunotherapy in Autoimmune Disease. Immune Regulation and Immunotherapy in Autoimmune Disease
289
338
.
Eilhard Mix, Saleh M. Ibrahim, Jens Pahnke, Änne Glass, Ignacio Mazón-Peláez, Susanne Lemcke, Dirk Koczan, Ulrike Gimsa, Sven Bansemer, Thomas Scheel, Thomas Karopka, Tobias Böttcher, Jana Müller, Eike Dazert, Veronica Antipova, Raimund Hoffrogge, Andreas Wree, Marlies Zschiesche, Ulf Strauß, Günther Kundt, Rolf Warzok, Lothar Gierl & Arndt Rolfs. (2006) 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Atorvastatin mediated effects depend on the activation status of target cells in PLP-EAE. Journal of Autoimmunity 27:4, pages 251-265.
Crossref
Crossref
G.-z. Liu, A. C. Gomes, P. Putheti, V. Karrenbauer, K. Kostulas, R. Press, J. Hillert, P. Hjelmstr?m & X.-G. Gao. (2006) Increased Soluble 4-1BB Ligand (4-1BBL) Levels in Peripheral Blood of Patients with Multiple Sclerosis. Scandinavian Journal of Immunology 64:4, pages 412-419.
Crossref
Crossref
Maria Fiammetta RomanoWilma BuffolanoRita BisogniRosario RussoRaffaele LiuzziMadeleine BundersMarie Louise NewellPatrizia Carandente Giarrusso. (2006) Increased CD154 Expression in Uninfected Infants Born to HIV-Positive Mothers Exposed to Antiretroviral Prophylaxis. Viral Immunology 19:3, pages 363-372.
Crossref
Crossref
R P Lisak, J A Benjamins, B Bealmear, B Yao, S Land, L Nedelkoska & D Skundric. (2016) Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immune-related molecules by central nervous system mixed glial cell cultures. Multiple Sclerosis Journal 12:2, pages 149-168.
Crossref
Crossref
Julia Tzu, Adam J. Mamelak & Daniel N. Sauder. (2006) Current advancements in the treatment of psoriasis: Immunobiologic agents. Clinical and Applied Immunology Reviews 6:2, pages 99-130.
Crossref
Crossref
C. K. Wong, L. C. W. Lit, L. S. Tam, E. K. Li & C. W. K. Lam. (2005) Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. Rheumatology 44:8, pages 989-994.
Crossref
Crossref
Gary S. Firestein. (2005) Immunologic Mechanisms in the Pathogenesis of Rheumatoid Arthritis. JCR: Journal of Clinical Rheumatology 11:3, pages S39-S44.
Crossref
Crossref
Joel M. Kremer. (2005) Selective Costimulation Modulators. JCR: Journal of Clinical Rheumatology 11:3, pages S55-S62.
Crossref
Crossref
A. Bossowski, A. Stasiak-Barmuta, M. Urban & A. Bossowska. (2005) Analysis of Costimulatory Molecules OX40/4-1BB (CD134/CD137) Detection on Chosen Mononuclear Cells in Children and Adolescents with Graves' Disease During Methimazole Therapy. Journal of Pediatric Endocrinology and Metabolism 18:12.
Crossref
Crossref
Francis J Dumont. (2004) CTLA4-Ig fusion proteins: promise for improved therapy of transplant rejection and autoimmune diseases. Therapy 1:2, pages 289-304.
Crossref
Crossref
Bettina Schreiner, Meike Mitsdoerffer, Bernd C. Kieseier, Lieping Chen, Hans-Peter Hartung, Michael Weller & Heinz Wiendl. (2004) Interferon-? enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. Journal of Neuroimmunology 155:1-2, pages 172-182.
Crossref
Crossref
Margot Zöller, Kevin J. McElwee, Mario Vitacolonna & Rolf Hoffmann. (2004) The progressive state, in contrast to the stable or regressive state of alopecia areata, is reflected in peripheral blood mononuclear cells. Experimental Dermatology 13:7, pages 435-444.
Crossref
Crossref
H. Wiendl, H. C. Lehmann, R. Hohlfeld, H.-P. Hartung & B. C. Kieseier. (2004) Multiple Sklerose: potenzielle Therapieansätze und Update laufender StudienMultiple sclerosis: potential therapeutic options and update of ongoing clinical trials. Der Nervenarzt 75:6, pages 536-552.
Crossref
Crossref
Gérald J. Prud’homme. (2004) Altering immune tolerance therapeutically: the power of negative thinking. Journal of Leukocyte Biology 75:4, pages 586-599.
Crossref
Crossref